FAK loss reduces BRAFV600E-induced ERK phosphorylation to promote intestinal stemness and cecal tumor formation
Preprint
- 3 April 2024
- preprint
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
Abstract
BRAFV600E mutation is a driver mutation in the serrated pathway to colorectal cancers. BRAFV600E drives tumorigenesis through constitutive downstream extracellular signal-regulated kinase (ERK) activation, but high-intensity ERK activation can also trigger tumor suppression. Whether and how oncogenic ERK signaling can be intrinsically adjusted to a “just-right” level optimal for tumorigenesis remains undetermined. In this study, we found that FAK (Focal adhesion kinase) expression was reduced in BRAFV600E-mutant adenomas/polyps in mice and patients. In Vill-Cre;BRAFV600E/+;Fakfl/fl mice, Fak deletion maximized BRAFV600E’s oncogenic activity and increased cecal tumor incidence to 100%. Mechanistically, our results showed that Fak loss, without jeopardizing BRAFV600E-induced ERK pathway transcriptional output, reduced EGFR (epidermal growth factor receptor)-dependent ERK phosphorylation. Reduction in ERK phosphorylation resulted in increased mRNA expression and stability of Lgr4, promoting intestinal stemness and cecal tumor formation. Together, our findings show that a “just-right” ERK signaling optimal for BRAFV600E-induced cecal tumor formation can be achieved via Fak loss-mediated downregulation of ERK phosphorylation.Keywords
All Related Versions
- Version 1, 2024-04-03, eLife preprints
- Published version: eLife, 13.
This publication has 61 references indexed in Scilit:
- Establishment of 3D Intestinal Organoid Cultures from Intestinal Stem Cells2017
- Negative feedback regulation of the ERK1/2 MAPK pathwayCellular and Molecular Life Sciences, 2016
- BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic InhibitionCancer Cell, 2015
- FAK Is required for c‐Met/β‐catenin‐driven hepatocarcinogenesisHepatology, 2014
- BRAF: A Driver of the Serrated Pathway in Colon CancerCancer Cell, 2013
- A Genetic Progression Model of BrafV600E-Induced Intestinal Tumorigenesis Reveals Targets for Therapeutic InterventionCancer Cell, 2013
- V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4aEMBO Molecular Medicine, 2010
- Ink4a/Arf and Oncogene-Induced Senescence Prevent Tumor Progression during Alternative Colorectal TumorigenesisCancer Cell, 2010
- Distinct Thresholds Govern Myc's Biological Output In VivoCancer Cell, 2008
- Back to the roots: the remarkable RAF oncogene storyCellular and Molecular Life Sciences, 2006